title: Time-to-Detection of Inducible Macrolide Resistance in Mycobacterium abscessus Subspecies and Its Association with the Erm(41) Sequevar.
abstract: Mutations in the erm(41) gene of M.abscessus group organisms are associated with differences in inducible macrolide resistance, with current recommendations being to hold rapidly growing isolates for up to 14 days in order to ensure that resistance which develops more slowly can be detected. This study aimed to determine the ideal incubation time for accurate identification of inducible macrolide resistance as well as to determine if there was an association between the time taken to detect inducible resistance in M.abscessus group organisms and their erm(41) sequevar. We amplified and sequenced the erm(41) genes of a total of 104 M.abscessus group isolates and determined their sequevars. The isolates were tested for phenotypic clarithromycin resistance at days 7, 10, 14 and 21, using Trek Diagnostics Sensititre RAPMYCO microbroth dilution plates. Associations between erm(41) gene sequevars and time to detection of resistance were evaluated using Fisher's exact test in R. The samples included in this study fell into 14 sequevars, with the majority of samples falling into Sequevar02 (16), Sequevar06 (15), Sequevar08 (7) and Sequvar 15 (31), and several isolates that were in small clusters, or unique. The majority (82.7%) of samples exhibiting inducible macrolide resistance were interpreted as resistant by day 7. Two isolates in Sequevar02, which has a T28C mutation that is associated with sensitivity, showed intermediate resistance at day 14, though the majority (13) were sensitive at day 14. The majority of isolates with inducible macrolide resistance fell into Sequevars 06,08 and 15, none of which contain the T28C mutation. These sequevars were analyzed to determine if there was any correlation between sequevar and time to detection of resistance. None was found. Based on these findings, we recommend the addition of a day 7 read to the CLSI guidelines to improve turn-around-times for these isolates. It is also recommended that erm(41) gene sequencing be added to routine phenotypic testing for the resolution of cases with difficult-to-interpret phenotypic results.
authors.affiliation: National Reference Centre for Mycobacteriology, National Microbiology Laboratory Public Health Agency of Canada, 1015 Arlington Street, Winnipeg, MB, Canada, R3E 3R2.
authors.forename: Sara
authors.initials: S
authors.lastname: Christianson
authors.affiliation: National Reference Centre for Mycobacteriology, National Microbiology Laboratory Public Health Agency of Canada, 1015 Arlington Street, Winnipeg, MB, Canada, R3E 3R2.
authors.forename: William
authors.initials: W
authors.lastname: Grierson
authors.affiliation: National Reference Centre for Mycobacteriology, National Microbiology Laboratory Public Health Agency of Canada, 1015 Arlington Street, Winnipeg, MB, Canada, R3E 3R2.
authors.forename: Daniel
authors.initials: D
authors.lastname: Kein
authors.affiliation: National Reference Centre for Mycobacteriology, National Microbiology Laboratory Public Health Agency of Canada, 1015 Arlington Street, Winnipeg, MB, Canada, R3E 3R2.
authors.forename: Andrea D
authors.initials: AD
authors.lastname: Tyler
authors.affiliation: National Reference Centre for Mycobacteriology, National Microbiology Laboratory Public Health Agency of Canada, 1015 Arlington Street, Winnipeg, MB, Canada, R3E 3R2.
authors.forename: Joyce
authors.initials: J
authors.lastname: Wolfe
authors.affiliation: National Reference Centre for Mycobacteriology, National Microbiology Laboratory Public Health Agency of Canada, 1015 Arlington Street, Winnipeg, MB, Canada, R3E 3R2.|Department of Medical Microbiology, University of Manitoba, Room 543-745 Bannatyne Avenue, Winnipeg, Manitoba, Canada, R3E 0J9.
authors.forename: Meenu K
authors.initials: MK
authors.lastname: Sharma
mesh_terms: D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001426:Bacterial Proteins / Q000235:genetics*; D017291:Clarithromycin / Q000494:pharmacology; D024881:Drug Resistance, Bacterial / Q000187:drug effects / Q000235:genetics*; D018942:Macrolides / Q000494:pharmacology*; D008780:Methyltransferases / Q000235:genetics; D008826:Microbial Sensitivity Tests; D009161:Mycobacterium / Q000187:drug effects / Q000235:genetics* / Q000302:isolation & purification; D012336:RNA, Ribosomal, 16S / Q000737:chemistry / Q000235:genetics / Q000378:metabolism; D017422:Sequence Analysis, DNA; D013997:Time Factors
chemical_list: D000900:Anti-Bacterial Agents; D001426:Bacterial Proteins; D018942:Macrolides; D012336:RNA, Ribosomal, 16S; D008780:Methyltransferases; D017291:Clarithromycin